Tag: SEO
News alerts
Latest content
- R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia

- Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million

- Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026

- ViiV Healthcare to unveil new HIV treatment data at AIDS 2026

- Jasper Therapeutics merges with Kira Pharmaceuticals

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
